Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_assertion description "[Calpain-10 (CAPN10) gene was the first candidate gene of T2D identified through genome-wide linkage and positional cloning, but few works have focused on the relationship of CAPN10 with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in EH patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_assertion evidence source_evidence_literature NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_assertion SIO_000772 20406624 NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_assertion wasDerivedFrom gad-20130706 NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_assertion wasGeneratedBy ECO_0000203 NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.
- gad-20130706 importedOn "2013-07-06" NP91039.RAU7fBWxhPnCWJzVEaiwNZeUis1F3DYLBpiYB8WW5-WZo130_provenance.